The company expired its plan on February 10, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,463 JPY | -0.75% | +1.60% | -15.76% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.76% | 233M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- 4554 Stock
- News Fuji Pharma Co., Ltd.
- Fuji Pharma Co., Ltd.'s Equity Buyback announced on February 9, 2021, has expired with 6,875,000 shares, representing 22.06% for ¥9,391.25 million.